Peter Carroll
Overview
Explore the profile of Peter Carroll including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
2364
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mohamad O, Li Y, Feng F, Hong J, Wong A, Kouzi Z, et al.
Prostate Cancer Prostatic Dis
. 2024 Aug;
PMID: 39128937
Delays in the work-up and definitive management of patients with prostate cancer are common, with logistics of additional work-up after initial prostate biopsy, specialist referrals, and psychological reasons being the...
2.
Tohi Y, Sahrmann J, Arbet J, Kato T, Lee L, Peacock M, et al.
Eur Urol Oncol
. 2024 Aug;
PMID: 39089946
Background And Objective: There is no consensus on de-escalation of monitoring during active surveillance (AS) for prostate cancer (PCa). Our objective was to determine clinical criteria that can be used...
3.
Bangma C, Doan P, Zhu L, Remmers S, Nieboer D, Helleman J, et al.
Eur Urol Oncol
. 2024 Jul;
PMID: 39025687
Background And Objective: Active surveillance (AS) has evolved into a widely applied treatment strategy for many men around the world with low-risk prostate cancer (or in selected cases intermediate-risk disease)....
4.
Djaileb L, Armstrong W, Thompson D, Gafita A, Farolfi A, Rajagopal A, et al.
Eur Urol
. 2023 Jul;
84(6):588-596.
PMID: 37482512
Background: In the initial staging of patients with high-risk prostate cancer (PCa), prostate-specific membrane antigen positron emission tomography (PSMA-PET) has been established as a front-line imaging modality. The increasing number...
5.
Jindal T, Zhang L, Deshmukh P, Reyes K, Chan E, Kumar V, et al.
Clin Genitourin Cancer
. 2023 Jun;
21(5):e394-e404.
PMID: 37316414
Introduction: Urothelial carcinoma with squamous differentiation (UCS) is associated with increased resistance to chemotherapy, but outcomes associated with newer therapies approved in this space over the last 5 to 10...
6.
Langlais C, Graff R, Van Blarigan E, Neuhaus J, Cowan J, Broering J, et al.
Br J Cancer
. 2023 May;
129(2):346-355.
PMID: 37217583
Background: Individual behaviours are associated with prostate cancer (PC) progression. Behavioural scores, comprised of multiple risk factors, allow assessment of the combined impact of multiple behaviours. Methods: We examined the...
7.
Waisman Malaret A, Chang P, Newcomb L, Faino A, Zheng Y, Zhu K, et al.
Urol Pract
. 2023 May;
8(5):576-582.
PMID: 37145399
Introduction: We analyzed the Canary Prostate Cancer Active Surveillance (PASS) cohort to determine if patients who had diagnostic biopsy at an off-site practice were at higher risk of reclassification than...
8.
9.
Beckmann K, Santaolalla A, Sugimoto M, Carroll P, Rubio J, Villers A, et al.
Prostate Cancer Prostatic Dis
. 2022 Aug;
26(2):403-409.
PMID: 36008540
Background: Currently, follow-up protocols are applied equally to men on active surveillance (AS) for prostate cancer (PCa) regardless of findings at their initial follow-up biopsy. To determine whether less intensive...
10.
Remmers S, Helleman J, Nieboer D, Trock B, Hyndman M, Moore C, et al.
Eur Urol Open Sci
. 2022 Jul;
41:126-133.
PMID: 35813247
Background: Active surveillance (AS) is a management option for men diagnosed with low-risk prostate cancer. Opinions differ on whether it is safe to include young men (≤60 yr) or men...